Hepatocellular carcinoma in the thalassaemia syndromes

被引:135
作者
Borgna-Pignatti, C
Vergine, G
Lombardo, T
Cappellini, MD
Cianciulli, P
Maggio, A
Renda, D
Lai, ME
Mandas, A
Forni, G
Piga, A
Bisconte, MG
机构
[1] Univ Ferrara, Dipartimento Med Clin & Sperimentale Pediat, Pediat Clin, I-44100 Ferrara, Italy
[2] Ctr Thalassemia, Santo Bambino Catania, Italy
[3] Univ Milan, Dipartimento Med, Milan, Italy
[4] Osped S Eugenio, Day Hosp Thalassemia, Rome, Italy
[5] Osped Cervello, Div Ematol 2, Palermo, Italy
[6] Univ Cagliari, Sez Talassemici Adulti, Dipartimento Sci Med, I-09124 Cagliari, Italy
[7] Osped Galliera, Div Pediat, Genoa, Italy
[8] Univ Turin, Dipartimento Pediat, Turin, Italy
[9] Ctr Studio Microcitemia, Cosenza, Italy
关键词
hepatocellular carcinoma; thalassaemia; hepatitis C; cirrhosis; iron overload;
D O I
10.1046/j.1365-2141.2003.04732.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hepatocellular carcinoma (HCC) frequently complicates hepatic cirrhosis secondary to viral infection or iron overload. Therefore, patients affected by thalassaemia syndromes have a theoretically high risk of developing the tumour. We collected data on patients attending Italian centres for the treatment of thalassaemia. Twenty-two cases of HCC were identified; 15 were male. At diagnosis, the mean age was 45 +/- 11 years and the mean serum ferritin was 1764 +/- 1448 mug/l. Eighty-six percent had been infected by hepatitis C virus. Nineteen of 22 cases were diagnosed after 1993, suggesting that this problem is becoming more frequent with the aging population of thalassaemia patients.
引用
收藏
页码:114 / 117
页数:4
相关论文
共 12 条
  • [1] Survival and disease complications in thalassemia major
    Borgna-Pignatti, C
    Rugolotto, S
    De Stefano, P
    Piga, A
    Di Gregorio, F
    Gamberini, MR
    Sabato, V
    Melevendi, C
    Cappellini, MD
    Verlato, G
    [J]. COOLEYS ANEMIA: SEVENTH SYMPOSIUM, 1998, 850 : 227 - 231
  • [2] HEPATOCELLULAR-CARCINOMA IN THALASSEMIA MAJOR
    BORGNAPIGNATTI, C
    DESTEFANO, P
    SESSA, F
    AVATO, F
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1986, 14 (06): : 327 - 328
  • [3] Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference
    Bruix, J
    Sherman, M
    Llovet, JM
    Beaugrand, M
    Lencioni, R
    Burroughs, AK
    Christensen, E
    Pagliaro, L
    Colombo, M
    Rodés, J
    [J]. JOURNAL OF HEPATOLOGY, 2001, 35 (03) : 421 - 430
  • [4] Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C
    Minola, E
    Prati, D
    Suter, F
    Maggiolo, F
    Caprioli, F
    Sonzogni, A
    Fraquelli, M
    Paggi, S
    Conte, D
    [J]. BLOOD, 2002, 99 (12) : 4588 - 4591
  • [5] Survival in β-thalassaemia major in the UK:: data from the UK thalassaemia register
    Modell, B
    Khan, M
    Darlison, M
    [J]. LANCET, 2000, 355 (9220) : 2051 - 2052
  • [6] Long-term survival in patients with hereditary hemochromatosis
    Niederau, C
    Fischer, R
    Purschel, A
    Stremmel, W
    Haussinger, D
    Strohmeyer, G
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : 1107 - 1119
  • [7] RANDOMIZED TRIAL OF EFFECTS OF INTERFERON-ALPHA ON INCIDENCE OF HEPATOCELLULAR-CARCINOMA IN CHRONIC ACTIVE HEPATITIS-C WITH CIRRHOSIS
    NISHIGUCHI, S
    KUROKI, T
    NAKATANI, S
    MORIMOTO, H
    TAKEDA, T
    NAKAJIMA, S
    SHIOMI, S
    SEKI, S
    KOBAYASHI, K
    OTANI, S
    [J]. LANCET, 1995, 346 (8982) : 1051 - 1055
  • [8] Benefits and complications of regular blood transfusion in patients with beta-thalassaemia major
    Prati, D
    [J]. VOX SANGUINIS, 2000, 79 (03) : 129 - 137
  • [9] Ryder S. D., 2003, Gut, V52, P1
  • [10] CLINICAL OUTCOMES AFTER TRANSFUSION-ASSOCIATED HEPATITIS-C
    TONG, MJ
    ELFARRA, NS
    REIKES, AR
    CO, RL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (22) : 1463 - 1466